New medication lowers triglyceride levels, yet does not decr

A new medication, pemafibrate, lowered triglyceride levels among adults with Type 2 diabetes yet did not decrease their cardiovascular risk, according to late-breaking science research presented today at the American Heart Association's Scientific Sessions 2022.

Related Keywords

United States , Boston , Massachusetts , Chicago , Illinois , American , Arunad Pradhan , Emily Henderson , American Heart Association , American Heart Association Scientific Sessions , Harvard Medical School , Scientific Sessions , Stroke Statistical , Reduce Cardiovascular Outcomes , Reducing Triglycerides , Diabetes , Medicine , Triglyceride , Type 2 Diabetes , Flood , Cardiovascular Disease , Cholesterol , Education , Heart , High Triglycerides , Hospital , Lipoprotein , Medical School , Placebo , Research , Statin , Stroke ,